377 related articles for article (PubMed ID: 19289428)
21. [18F]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography in predicting radiation pneumonitis.
Song H; Yu JM; Kong FM; Lu J; Bai T; Ma L; Fu Z
Chin Med J (Engl); 2009 Jun; 122(11):1311-5. PubMed ID: 19567143
[TBL] [Abstract][Full Text] [Related]
22. Giant cell arteritis on 18F-FDG PET/CT.
Heston TF; Szabo Z
Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
[TBL] [Abstract][Full Text] [Related]
24. 18F-FDG-PET/CT as an indicator for resection of pulmonary epithelioid hemangioendothelioma.
Watanabe S; Yano F; Kita T; Soga S; Shinmoto H; Kosuda S; Ozeki Y; Aida S; Sakata I
Ann Nucl Med; 2008 Jul; 22(6):521-4. PubMed ID: 18670859
[TBL] [Abstract][Full Text] [Related]
25. Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT.
Wassélius J; Larsson S; Jacobsson H
Ann Nucl Med; 2009 Jan; 23(1):59-64. PubMed ID: 19205839
[TBL] [Abstract][Full Text] [Related]
26. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D
J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
[TBL] [Abstract][Full Text] [Related]
27. (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography findings are different between invasive and noninvasive pulmonary aspergillosis.
Kim JY; Yoo JW; Oh M; Park SH; Shim TS; Choi YY; Ryu JS
J Comput Assist Tomogr; 2013; 37(4):596-601. PubMed ID: 23863538
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
[TBL] [Abstract][Full Text] [Related]
29. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
Cheon GJ; Kim MS; Lee JA; Lee SY; Cho WH; Song WS; Koh JS; Yoo JY; Oh DH; Shin DS; Jeon DG
J Nucl Med; 2009 Sep; 50(9):1435-40. PubMed ID: 19690035
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot Study.
Jacquelin V; Mekinian A; Brillet PY; Nunes H; Fain O; Valeyre D; Soussan M
Eur J Radiol; 2016 Dec; 85(12):2200-2205. PubMed ID: 27842667
[TBL] [Abstract][Full Text] [Related]
31. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.
Oikawa M; Kagaya Y; Otani H; Sakuma M; Demachi J; Suzuki J; Takahashi T; Nawata J; Ido T; Watanabe J; Shirato K
J Am Coll Cardiol; 2005 Jun; 45(11):1849-55. PubMed ID: 15936618
[TBL] [Abstract][Full Text] [Related]
32. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
[TBL] [Abstract][Full Text] [Related]
33. The effects of N-butylscopolamine on bowel uptake: an 18F-FDG PET study.
Emmott J; Sanghera B; Chambers J; Wong WL
Nucl Med Commun; 2008 Jan; 29(1):11-6. PubMed ID: 18049092
[TBL] [Abstract][Full Text] [Related]
34. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results.
Ambrosini V; Zompatori M; De Luca F; Antonia D; Allegri V; Nanni C; Malvi D; Tonveronachi E; Fasano L; Fabbri M; Fanti S
J Nucl Med; 2010 Dec; 51(12):1950-5. PubMed ID: 21078794
[TBL] [Abstract][Full Text] [Related]
35. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis.
Umeda Y; Demura Y; Morikawa M; Anzai M; Kadowaki M; Ameshima S; Tsuchida T; Tsujikawa T; Kiyono Y; Okazawa H; Ishizaki T; Ishizuka T
J Nucl Med; 2015 Dec; 56(12):1869-75. PubMed ID: 26359263
[TBL] [Abstract][Full Text] [Related]
37. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.
Win T; Thomas BA; Lambrou T; Hutton BF; Screaton NJ; Porter JC; Maher TM; Endozo R; Shortman RI; Afaq A; Lukey P; Ell PJ; Groves AM
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):337-42. PubMed ID: 23942907
[TBL] [Abstract][Full Text] [Related]
38. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W
Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
[TBL] [Abstract][Full Text] [Related]
39. Patterns of pulmonary tuberculosis on FDG-PET/CT.
Soussan M; Brillet PY; Mekinian A; Khafagy A; Nicolas P; Vessieres A; Brauner M
Eur J Radiol; 2012 Oct; 81(10):2872-6. PubMed ID: 21945403
[TBL] [Abstract][Full Text] [Related]
40. Is
Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
